March 9, 2010
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)today announced that Dr. James Forsythe, MD, HMD, is experiencing continuous success with his Forsythe Immune Therapy (FIT) Protocol. Dr. James Forsythe, MD, HMD, is a board certified oncologist and a member of HST Global Inc.’s Board of Directors and Scientific Advisory Board.

Dr. Forsythe’s existing study is meeting with 70-80% efficacy in clinical treatment of Stage IV cancers in a test of 450 patients. The highlight of the study is in stage IV prostate cancer where they have met with 86% efficacy with prostate cancer patients over 55 months through the application of his "FIT" Protocol.

Ronald Howell President and CEO of HST Global, Inc. stated, "We are encouraged by the continued success Dr. Forsythe is experiencing with his FIT protocol. The updated study results demonstrate the efficacy of the FIT Protocol."

Read the full news release on BusinessWire.com

February 16, 2010
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)today announced that it has entered into a formal marketing agreement with Dr. James Forsythe, MD, HMD, board certified oncologist and a member of HST Global Inc.’s Board of Directors and Scientific Advisory Board.

According to the agreement, Dr. Forsythe and HST Global will be working together to manufacture, market and sell Dr. Forsythe’s Technologies under the trademark "FIT". HST Global will be allowed to employ Dr. Forsythe’s image, expertise and related intellectual property. HST Global has acquired an exclusive license to manufacture, market and sell these products throughout the world and has obtained the exclusive right to use Dr. Forsythe’s identification and endorsement in connection with the marketing, sale and distribution of the FIT Technology Products.

Mr. Ron Howell, CEO and President of HST Global, Inc., stated, "This agreement significantly expands the relationship developed with Dr. Forsythe over the past two years. The company is poised to experience growth in 2010 through our current Wellness Clinic development strategies in Ecuador and Panama coupled with the marketing and sales of our line of nutraceutical products. The company continues to place emphasis on efforts to provide a growing world population with alternative integrative science-based products and treatments."

Read the full news release on BusinessWire.com

February 8, 2010
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)today announced that it has identified a global partner for the possible development of a Clinical Treatment Facility in Panama.

This information, coupled with the recent announcement pertaining to the Ecuadorian Treatment Facility, further signifies HST Global’s commitment to develop Cancer Treatment Centers worldwide. As previously stated, HST Global is relying on international markets to reach a worldwide audience. The Company is continually being presented with opportunities to bring its integrative science-based cancer treatment protocols to a global population.

Mr. Ron Howell, CEO and President of HST Global, Inc., stated, "At HST, we continue to take advantage of the relationships we have groomed over the past year. The fact we have partners that are familiar with the demographic idiosyncrasies, economic conditions and political climate of a particular region is invaluable during the initial stages of developing a facility. Through this partnership, we will be able to exploit this indigenous knowledge as well as leverage and align our resources in an effort to develop our Panamanian Treatment Facility."

Read the full news release on BusinessWire.com

February 2, 2010
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)today announced that it has targeted Ecuador for development of a Clinical Treatment Facility.

As the acceptance of integrative science-based cancer treatments worldwide continues to grow, so has HST Global, Inc.’s strategy of opening our own brand of Cancer Treatment Centers. To further facilitate this approach, HST Global is relying on international markets to reach a worldwide population. HST feels Ecuador will provide a significant platform to benefit patients on a global scale.

Mr. Ron Howell, CEO and President of HST Global Inc., stated, "We are impressed with the demographic diversity and economic infrastructure that Ecuador has developed. They have built world-class facilities that offer cutting edge technologies that complement our clinical protocols. We are in the initial phases of developing our entry strategy for Ecuador through relationships we have developed worldwide. These global partners will allow HST to leverage itself and align its resources in an effort to develop an Ecuadorian facility."

Read the full news release on BusinessWire.com

Read news from 2009.